Anticancer Therapeutic Strategies Targeting p53 Aggregation
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms231911023
Abstract: p53 is a tumor suppressor protein that is mutated in more than 50% of cancer cases. When mutated, it frequently results in p53 oncogenic gain of function (GOF), resulting in a greater tendency to aggregate… read more here.
Keywords: aggregation; anticancer therapeutic; therapeutic strategies; p53 aggregation ... See more keywords